Skip to main content
. 2022 Mar 3;2022(3):CD014328. doi: 10.1002/14651858.CD014328

NCT02113280.

Study name DEMAND ‐ DEgenerative Meniscal Tears ‐ Arthroscopy vs. Dedicated Exercise
Official title: Randomised Controlled Trial Comparing Arthroscopy With Physiotherapy for Degenerative Meniscal Tears
Methods Study design: prospective parallel‐arm randomised controlled trial
Setting: North Tyneside General Hospital, UK
Trial time period: December 2015 to December 2018
Interventions: arthroscopic surgery versus physiotherapy
Sample size calculations: not reported
Analysis: not reported
Participants Inclusion criteria
  • Age over 45 years

  • Knee pain in the presence of a medial meniscal tear on MRI


Exclusion criteria
  • History of trauma to the knee or ipsilateral lower limb in the past 2 years

  • Inability to engage in post‐operative rehabilitation

  • Lacking capacity to consent

  • Evidence of infection

  • Previous knee surgery other than arthroscopy (diagnostic or partial meniscectomy)

  • Neurological disease

  • Inflammatory arthritis

  • Loose bodies

  • Ligament injuries causing symptomatic instability

  • Women who are pregnant

  • Have current signs or symptoms of severe, progressive or uncontrolled renal, hepatic, haematological, gastrointestinal, endocrine, pulmonary, cardiac, neurologic, or cerebral disease

  • Uncontrolled disease states, such as moderate/severe asthma, chronic obstructive pulmonary disease (COPD) or inflammatory bowel disease, where flares are commonly treated with oral or parenteral glucocorticoids, or recurrent infections

Interventions Arthroscopy: participants to receive knee arthroscopy and meniscal debridement
Physiotherapy: outpatient standardised physiotherapy regime with focus on exercise therapy
Outcomes Outcomes will be measured at baseline, 6 weeks and 6, 12 and 24 months.
Primary outcome
  • Change in Knee injury and Osteoarthritis Outcome Score


Secondary outcomes
  • SF‐12 (12‐item short form survey)

  • Pain visual analogue score

Starting date December 2015
Contact information Sarah Johnson‐Lynn, MBBS Specialty Registrar, Northumbria Healthcare NHS Foundation Trust 08448118111 ext 2508 selynn@doctors.org.uk
Derek Kramer, MBBS 08448118111 ext 2508 derek.kramer@northumbria‐healthcare.nhs.uk
Notes Clinical trial registration:NCT02113280
Trial status: withdrawn (failed funding application)
Expected completion date: December 2018